Google DeepMind launched AlphaGenome, an AI tool that predicts how DNA mutations disrupt gene regulation.
The system analyses up to one million DNA letters at once to assess mutation impact.
Researchers trained it on human and mouse genetic databases.
AlphaGenome helps identify disease-driving mutations linked to cancer, heart disease, and autoimmune disorders.
Scientists say it could speed drug discovery and enable targeted gene therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
Golden Gate Times delivers powerful stories, breaking news, sports, and culture—bringing bold perspectives and timely updates to keep readers informed, inspired, and connected worldwide.
We’re social. Connect with us:
© 2026 Golden Gate Times. All Rights Reserved.